Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 28, Issue 2, 2012, Pages 188-197

  Curtis, Kelly A ^a   Kennedy, M Susan ^a   Charurat, Man ^b   Nasidi, Abdulsalami ^c   Delaney, Kevin ^a   Spira, Thomas J ^a   Owen, S Michele ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Nigerian Federal Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; MICROSPHERE; PROTEIN P66; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIRUS DETECTION;

ALGORITHMS; ANTIBODY AFFINITY; COHORT STUDIES; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HOMOSEXUALITY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MOLECULAR SEQUENCE DATA; PUBLIC HEALTH; RECOMBINANT PROTEINS;

EID: 81155162373     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0037     Document Type: Article

References (33)

1. Janssen RS, Satten GA, Stramer SL, et al.: New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280(1):42-48. (Pubitemid 28414995)
2. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008;300(5):520-529.
3. Parekh BS and McDougal JS: Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res 2005;121(4):510-518. (Pubitemid 40691380)
4. Murphy G and Parry JV: Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008;13(36).
5. Guy R, Gold J, Calleja JM, et al.: Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: A systematic review. Lancet Infect Dis 2009;9(12):747-759.
6. Cooper DA, Imrie AA, and Penny R: Antibody response to human immunodeficiency virus after primary infection. J Infect Dis 1987;155(6):1113-1118. (Pubitemid 17080483)
7. Gallarda JL, Henrard DR, Liu D, et al.: Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J Clin Microbiol 1992;30(9):2379-2384.
8. Dobbs T, Kennedy S, Pau CP, McDougal JS, and Parekh BS: Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42(6):2623-2628. (Pubitemid 38747513)
9. Parekh BS, Kennedy MS, Dobbs T, et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18(4):295-307. (Pubitemid 34253148)
10. Suligoi B, Massi M, Galli C, et al.: Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 2003;32(4):424-428. (Pubitemid 36363157)
11. Barin F, Meyer L, Lancar R, et al.: Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005;43(9):4441-4447. (Pubitemid 41298225)
12. Kothe D, Byers RH, Caudill SP, et al.: Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003;33(5):625-634. (Pubitemid 36975851)
13. Killian MS, Norris PJ, Rawal BD, et al.: The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. AIDS Res Hum Retroviruses 2006;22(7):640-647. (Pubitemid 44061400)
14. Hayashida T, Gatanaga H, Tanuma J, and Oka S: Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2008;24(3):495-498. (Pubitemid 351457743)
15. Selleri M, Orchi N, Zaniratti MS, et al.: Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies. J Acquir Immune Defic Syndr 2007;46(2):145-150. (Pubitemid 47482609)
16. Young CL, Hu DJ, Byers R, et al.: Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika- LS assay for detecting recent HIV-1 subtype B′ or E infection in Thailand. AIDS Res Hum Retroviruses 2003;19(6):481-486. (Pubitemid 36793768)
17. Karita E, Price M, Hunter E, et al.: Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21(4):403-408.
18. Laeyendecker O, Rothman RE, Henson C, et al.: The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital Emergency Department. J Acquir Immune Defic Syndr 2008;48(2):211-215.
19. Laeyendecker O, Oliver A, Astemborski J, et al.: Improved Precision of Cross-sectional HIV Incidence Testing Using a Multi-assay Algorithm that Included BED and an Avidity Assay with Modified Assay Cutoffs. Paper presented at the 17th Conference on Retroviruses and Opportunistic Infections, 2010, San Francisco, CA.
20. Waterboer T, Sehr P, and Pawlita M: Suppression of nonspecific binding in serological Luminex assays. J Immunol Methods 2006;309(1-2):200-204. (Pubitemid 43190816)
21. Seage GR, 3rd, Holte SE, Metzger D, et al.: Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 2001;153(7):619-627. (Pubitemid 32250969)
22. Celum CL, Buchbinder SP, Donnell D, et al.: Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis 2001;183(1):23-35. (Pubitemid 32043038)
23. Kaplan JE, Spira TJ, Fishbein DB, and Lynn HS: Ten-year follow-up of HIV-infected homosexual men with lymphadenopathy syndrome: Evidence for continuing risk of developing AIDS. J Acquir Immune Defic Syndr 1992;5(6): 565-570.
24. Kaplan JE, Spira TJ, Fishbein DB, Pinsky PF, and Schonberger LB: Lymphadenopathy syndrome in homosexual men. Evidence for continuing risk of developing the acquired immunodeficiency syndrome. JAMA 1987;257(3): 335-337. (Pubitemid 17058663)
25. Chawla A, Murphy G, Donnelly C, et al.: Human immuno-deficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)- seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol 2007;45(2):415-420.
26. Suligoi B, Galli C, Massi M, et al.: Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 2002;40(11):4015-4020. (Pubitemid 35285783)
27. Tomaras GD, Yates NL, Liu P, et al.: Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol 2008;82(24): 12449-12463.
28. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, and McDougal JS: Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001;17(2):137-146. (Pubitemid 32099298)
29. Hargrove JW, Humphrey JH, Mutasa K, et al.: Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22(4):511-518. (Pubitemid 351317293)
30. UNAIDS Reference Group on estimates, modelling and projections - statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Wkly Epidemiol Rec 2006;81(4):40.
31. Brookmeyer R: Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol Rev 2010;32(1):26-37.
32. Sakarovitch C, Rouet F, Murphy G, et al.: Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr 2007;45(1):115-122. (Pubitemid 46684451)
33. Schupbach J, Gebhardt MD, Tomasik Z, et al.: Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med 2007;4(12):e343.